5.1(top 3%)
Impact Factor
5.4(top 3%)
extended IF
73(top 5%)
H-Index
1.6K
authors
3.4K
papers
46.2K
citations
4.5K
citing journals
24.6K
citing authors

Most Cited Articles of Drug Development Research

TitleYearCitations
Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen19951.2K
Magnetic nanoparticles for drug delivery2006645
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics2020513
Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors2006364
Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers1995335
Ectonucleotidases: Some recent developments and a note on nomenclature2001331
Anticonvulsant activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a, d]cyclohepten-5, 10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties1982290
Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs1992256
Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [a, d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties1982234
Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design2010208
Integrin alpha(v)beta(3)-Targeted Cancer Therapy2008205
The Role of miR-21 in Cancer2015202
Targeted nanoparticles for detecting and treating cancer2006185
1,4-Dihydropyridine Ca2+ channel antagonists and activators: A comparison of binding characteristics with pharmacology1984181
Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 receptor blocker1986179
Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects1988167
Molecular Architecture of G Protein-Coupled Receptors1996164
Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine1991162
Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: Drugs as foreign/stressful stimuli1988159
Gangliosides in treatment of neural injury and disease1988156
Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies2004152
Current drug targets for Alzheimer's disease treatment2002146
Viruses and their uses in nanotechnology2006140
Extracellular purine metabolism1996138
Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine1994134